SWOT Analysis for CytomX Therapeutics Inc

Add SWOT widget to your site/app

Positive Breakout First Resistance ( LTP > R1)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Rising Momentum: Momentum Score Weekly Gainers
Turnaround Potential (DVM)
High Normalized Momentum Score
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over Half Year (6 Months)
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Stocks whose current price is 20% higher than week low, and more than previous close
Weekly Strategy: High Momentum Score Stocks (subscription)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Relative Outperformance versus Industry over 1 Month
Near 52 Week High
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock gained more than 20% in one month
Annual Net Profits improving for last 2 years
Positive Breakout (LTP > R1)
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter